← Leaderboards
Keith James Jenne
Jaan Biotherapeutics, Inc.
$537,141
Attributed
$1,611,423
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,611,423 · 2
By mechanism
R44$1,290,338 · 1
R43$321,085 · 1
Top collaborators
- Bhawanjit K Brar2 shared
- Kirk Peterson2 shared
Most similar at Jaan Biotherapeutics, Inc.
Same institution · by research overlap
- Bhawanjit K Brar$1,020,224
Others in their field
Other Emerging Leaders on “Deterioration”
- Barbara Halina Braffett · George Washington University$7,285,878
- Patricia Pavlinac · University Of Washington$6,692,400
- Sook-Lei Liew · University Of Southern California$6,121,666
- Kei M Igarashi · University Of California-Irvine$5,826,395
- Patricio Sepulveda · Amplo Biotechnology, Inc.$5,506,739
- Francesca E. Duncan · Northwestern University At Chicago$5,269,165
Research focus
DeteriorationHeartCause Of DeathDesignFamily SuidaeGrantCardiac MyocytesCardiac VolumeCicatrixDependovirusDoseFailureAnimalsGood Laboratory PracticeAcuteCardiacBiological Response Modifier TherapyCardiac RegenerationBlood FlowCessation Of LifeClinically RelevantCoronaryAdultHeart Failure